fDi Markets Newswire:

Beyond biotech

Cologne’s BioCampus extends its remit to other disciplines

Cologne's biotech centre BioCampus is branching out from its original purpose. Director André van Hall tells Natasha Turak why an interdisciplinary approach is the way forward.

Ute Berg

Tech-driven companies central to Cologne's future

Ute Berg, general manager of BioCampus Cologne and deputy mayor for economic development and real estate, explains to fDi how innovation and technology are vital for the future prosperity of the city.

biopharma

Biotech-pharma hotspots on the up

Locations are taking advantage of the growing demand for healthcare, bringing together academia, big industry, start-ups, hospitals and sources of capital to create thriving specialised biomedical-pharmaceutical clusters.

Think Tank

Think Tank: how to stay one step ahead of an outbreak

Building an innovation culture can help countries prepare for the outbreak of diseases such as Ebola, write Rachel Chu and Meir Pugatch of Pugatch Consilium.

Alvogen benefits from bio diversity

Alvogen benefits from bio diversity

The rapid growth of Alvogen is impressive by any standards, but for a company operating in the ever-changing pharmaceuticals market it is even more remarkable. The secret of Alvogen's success lies in its decision to expand and diversify its company function, its product line and its geographical markets.

Renault, Figuerelas, Spain

Built on FDI: Spain's economic recovery story

After years of struggle, Spain's economy seems to have turned a corner. This is in no small part down to its burgeoning FDI markets, particularly in the financial services, property, manufacturing and construction sectors.

GSK in China

A healthy long-term outlook for China's pharmaceutical sector

Allegations of corruption have dealt a blow to several international pharmaceutical companies operating in China. Despite this, the long-term prognosis for the industry remains good, with huge growth potential in what is set to become the world's second largest drugs market by 2016.

Tianjin siezes the tech initiative

Tianjin seizes the tech initiative

The Chinese city of Tianjin may lie in the shadow of investment behemoths Beijing and Shanghai, but it is still at the forefront of the country’s high-tech focus, with the Tianjin Economic-Technological Development Area central to its strong FDI appeal.

Spreading the wealth

Buffalo and Rochester look to up share of New York state spoils

Investment into the state of New York is naturally dominated by New York City, leaving the likes of Buffalo and Rochester trailing in its wake. However, after years of decline, the two cities look to be on the cusp of a revival, thanks in no small part to the state governor's ambitious investment plans.

EU policy threat to clinical trials

Experts are warning that EU policy on clinical trials in Europe could hamper innovation and investment, and stifle growth. 

We use cookies to improve site performance and enhance your user experience. If you’d like to disable cookies on this device, please see our cookie management page. If you close this message or continue to use the site, you consent to our use of cookies on this device in accordance with our cookie policy, unless you disable them.